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Supporting information can be found in the online version of this abstract Objectives: The purpose of this work was to assess the existence of a connection between the atypical glandular cells (AGC) on cervical smears and gynecological changes on ultrasound. Methods: A random sample of 60 women with AGC was selected between 143 cases detected in a tertiary care hospital between 2012 and 2016. Pelvic ultrasounds were analysed to determine whether there were any changes. Results: Of the 58 women, 13 were excluded due to insufficient information and 1 awaits investigation. A total of 44 cases was considered. The mean age was 50,7+/-13,0 years old (31-88), the majority of women was Caucasian (84,1%), and 75,0% had vaginal deliveries. 40,9% was menopausal at the time of smear collection.
On the ultrasound evaluation, 7 women (15,9%) had an endometrial thickening, suspect of malignancy, and in 5 of these (11,4%) endometrial adenocarcinoma was confirmed in the hystological analysis, having been treated accordingly.
As far as benign pathology was concerned, the most common finding was adenomyosis, present in 75,0% of women (n=33), including 3 of the ones with malignancy. Some of these women had other myometrial findings, such as fibromyomas, but the majority (63,6% n=21) only had adenomyosis. Some women had other ultrasound features apart from adenomyosis, which varied from small benign ovarian cysts to endocervical cysts, endometrial polyps and other findings.
Most women repeated the cervical smear and had normal results on follow-up. Conclusions: Since some women with AGC have malignant pathology, it is of the utmost importance to investigate the cervix, endometrium and adnexa thoroughly. Fortunately, the majority of women with AGC only has benign pathology, such as adenomyosis. After discarding malignancy, adenomyosis seems to be the most consistent change throughout the sample.
Since these findings are based on a small sample, further studies are warranted in order to better determine whether there are any consistent sonographic changes associated with AGC. 
Hospital Clínic Barcelona, Barcelona, Spain
Objectives: To study the correlation between ultrasonographic, hysteroscopic and histologic findings of endometrial changes associated with a standard 3-month ulipristal acetate treatment. Methods: A prospective observational study of women undergoing treatment with ulipristal acetate was conducted in a University teaching and research hospital, tertiary referral centre. Seventy-one women with one or more symptomatic myomas were monitored after a 12-week cycle of ulipristal administration (5 mg/day). Patients underwent pre-and post-treatment transvaginal ultrasound and hysteroscopy; guided endometrial samples were collected after treatment to reveal the presence of PAEC features (Progesterone-receptor modulator associated endometrial changes). Endometrial ultrasound and hysteroscopic findings were recorded (endometrial thickness, vascularisation, appearance). Results: Ultrasound findings were normal in most patients but in 6 (8.45%) showed patterns suggestive of endometrial changes (only one showed PAEC after histological analysis); The mean endometrial thickness did not significantly change during treatment except in 3 patients (4.2%) with a thickness ≥16 mm. Hysteroscopically, the endometrium was altered in 5 (7.04%) patients after ulipristal treatment; of these, 4 patients presented histological findings of PAEC. The mean volume of the dominant fibroid was 243 cc (95% CI, 158.71-327.28). Reductions, albeit not statistically significant, were observed in the mean dominant fibroid volume and uterine volume. Conclusions: Our results seem to indicate that hysteroscopic findings are better correlated with the pathological analysis than transvaginal ultrasound for detecting PAEC patterns related to ulipristal acetate treatment.
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Ulipristal acetate in the treatment of fibroids: report of the initial experience of a tertiary centre in Portugal J. Pereira, A. Costa, J. Ferreira, J. Beires
Centro Hospitalar São João, Viseu, Portugal
Objectives: Ulipristal acetate (UPA) is a novel alternative in the medical management of fibroids. Its efficacy and safety as a preoperative treatment have already been shown; besides the fast and effective control of the fibroid-associated bleeding, another advantage is the reduction in the size of fibroids, which lasts for at least 6 months after the treatment. The objective of this study was to evaluate the results of the treatment with UPA in a tertiary hospital in Portugal -the primary outcome was defined as the reduction in the size of the dominant fibroid (the authors defined the biggest diameter as the standard measurement). Methods: Retrospective analysis of standardised medical records of all women to whom UPA was prescribed between January of 2013 and December of 2016 at Centro Hospitalar de São João. The inclusion criteria were: women older than 18-years-old who underwent a 3-month treatment with UPA and who had an imagiological exam describing the size of the dominant fibroid within 6 months preceding the treatment and another one up to three months after its completion. Statistical analysis was performed using SPSS Statistics ® , version 22.0, IBM ® software, with a p value inferior to 0.05 indicating statistical significance. Results: From the 155 women to whom UPA was prescribed, only 73 cases were eligible. The mean age of the patients was 42.41 years old; 32% of them were nulliparous. The mean reduction in the dominant fibroid diameter after one cycle of UPA was 5.23mm (SD= 13.60mm): it was statistically significant (p< 0,05). Conclusions: Despite the small number of patients included, the reported results go in line with other studies published so far. As so, the authors believe that UPA is a valid alternative in the treatment of fibroids.
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Thickened endometrium secondary to continuous ulipristal acetate treatment M. Munmany, C. Ros, M. Rius, M. Gracia, R. Nonell, M. Martinez-Zamora, F. Carmona
Gynecology Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
A 37 year-old nulliparous woman was referred to our centre due to hypermenorrhea and uterine leiomyomatosis. She had had two previous laparotomic multiple myomectomies in other centres. She was complaining from heavy menses as well as pelvic pain. At ultrasound examination, she had multiple intramural myomas as well as four submucous myomas of less than two centimetres. The rest of the myometrium appeared as adenomiotic (myometrial heterogenicity, ecogenic linear striation, infiltration of Junctional Zone).
After trying treatment with progesterone with no symptomatic control, ulipristal acetate was prescribed. The patient took the treatment continuously for ten months (at her choice without medical agreement). The ultrasound examination at this point showed up a thickened heterogeneous endometrium (34 mm). A hysteroscopic exam was then decided, and revealed a thickened with increased vessels endometrium, compatible with PAEC (Progesterone Associated Endometrial Changes). The patient stopped the treatment and at two months follow up showed a normal echographic, hysteroscopic and histologic endometrial pattern. Since the patient wanted to preserve uterus, a hysteroscopic resection of the submucous myomas was decided. During the surgery, four myomas were resected completely and adenomyosis was confirmed. Objectives: To evaluate the accuracy of gynecological ultrasound for focal endometrial pathology, using data of ultrasound, hysteroscopy and histology. Methods: We defined focal pathology on ultrasound as the presence of polyp, myoma or unspecified focal pathology. We studied all women with suspicion of focal endometrial pathology in gynecological ultrasound between January 2013 and December 2014. Of all these women, we went to see how many had hysteroscopy and/or histology results and then we studied the correlation between the findings. Results: There were 804 women with abnormal endometrial findings in ultrasound, of which 352 with focal pathology. The age of women in this last group varied between 20 and 87, with an average of 55.1 years. 179 women were post-menopausal. The endometrial thickness varied between 4 and 48 mm.
164 women were submitted to hysteroscopy. In 2 cases the procedure was abandoned for uterine perforation and in 20 cases there was no focal pathology. There were 4 cases of synechiae, 5 septums, 13 uterine myomas, 119 uterine polyps and 1 case suspected of malignant neoplasia in a polypoid formation. There were 3 confirmed cases of malignancy, all present in polypoid formations.
16 women were directly submitted to hysterectomy. 7 had uterine myoma and the others had no focal pathology.
In this sample, we obtained a positive predictive value of ultrasound for focal endometrial pathology of 82.7%. We could not find any cut-off value of endometrial thickness below which there is never a focal pathology and above which there is always pathology. All women with endometrial malignancy had an endometrial thickness above 5 mm. Conclusions: Our women with suspected focal endometrial pathology on gynecological ultrasound had a probability of actually having an abnormal finding of 82.7%. The endometrial thickness value did not allow us to distinguish women with and without focal pathology, however no woman with an endometrium with less than 5 mm had malignant focal pathology.
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Ultrasound markers of impending intrauterine adhesions: new data about natural history and prevention Objectives: Intrauterine adhesions (IUA) can be detected on transvaginal ultrasound scan (TVS), but there is limited knowledge about the length of time between the trigger endometrial injury and their formation. In this study we analysed the appearances of the uterine cavity in an attempt to identify ultrasound features which are predictive of developing IUA. Methods: This was a series of five women who presented to our unit with persistent bleeding following surgical evacuation for retained placental tissue after full term pregnancies or first trimester miscarriage. Each woman underwent a detailed two-and three-dimensional TVS assessment of the uterine cavity by an expert operator. All women were managed expectantly and followed up prospectively in our unit. Once there were clear signs of IUA on TVS, hysteroscopy was performed. Results: In all women we observed similar morphological features on the initial examination: a distended uterine cavity with heterogenous thick material and thin endometrium with a partial loss of baseline layer. Two women were prescribed oestrogen supplementation (Cyclo-Progynova™ 2mg,day/four weeks). All women developed IUA in the median time of 18 weeks (range, 6-53). They all underwent a hysteroscopy which showed severe IUA in four and moderate IUA in one woman. Conclusions: Our findings show that in some women, there are distinctive ultrasound features that precede the development of IUA. This suggests a ''pre-IUA'' state may exist and that their development can be a gradual process. Our findings also question the value of hormonal supplementation for their prevention. Further prospective studies are needed however to establish the sensitivity and specificity of our findings as a predictor for the development of IUA following intrauterine surgery.
